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Introduction
Methicillin resistant Staphylococcus aureus (MRSA) is
one of the most common pathogens responsible for
hospital infections and, as recently discovered, also for
community acquired infections. It can cause a broad
spectrumofinfectionsthroughlocalinvasion,toxinmedi-
ated diseases to generalized infections. S. aureus is a
bacterium commonly present in the human population
and constant or part time carrier frequency in the nasal
vestibule is estimated at 30–60% [6], [8], [19], [26].
Therapeutic problems are mainly caused by infections
with strains, which are resistant not only to methicillin
(methicillin-resistant S. aureus, MRSA) and in con-
sequence to all β-lactam antibiotics but also to many
other group of antimicrobial therapeutics. The presence
of this pathogen enables its local distribution e.g. within
a hospital ward and/or between hospital wards (hospital
or healthcare acquired) HA-MRSA [2], [12], [13], [22],
[23]. When such a strain carries genes responsible for
the resistance to many antibiotics, as in the in case of
HA-MRSA strains [2], [7], [12], [13], [22], [23]; then it
becomes a great problem both, therapeutically – due to
the limited number of antibiotics available, as well as
economically – due to the necessity of expensive drugs
and the prolonged time spent in the hospital [4], [5], [9],
[10],[15],[21],[25].Theincreaseofcostsisalsoaresult
ofspecialprocedureinitiationsneededforcontrollingthe
wide-spread of the pathogen, such as hygienic and isol-
ation procedures, identifying the carrier and, next, its
eradication [1], [13], [17]. In some countries MRSA can
constitute up to 80% of all S. aureus isolates in hospitals
[14]. In some Polish hospitals the percentage of MRSA
strains reached up to ~60% [20]. The frequency of
bacteremiaofthisetiology,accordingtoresearchcarried
out in the years 1999–2000 in Europe, depending on
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markandtheNetherlands)[24].Accordingtotheresearch
of SENTRY carried out in the years 1997–1999 in USA,
Canada,LatinAmerica,andWesternPacific,thepercent-
age of infection in these areas was 25.3; 19.2; 20.6 and
21.6, respectively [3]. In our study we have analyzed the
impact of modified procedures on epidemiological situ-
ation of MRSA during the last three years comparing two
similar hospitals in Northern Poland.
Material and methods
A three-year-lasting period (2008–2010) was analyzed.
Only the first isolate from one patient and no duplicate
were taken into account.
Hospital no. 1
Gdansk is the city that lies on the southern edge of
Gdansk Bay (of the Baltic Sea), in a conurbation with the
cityofGdynia,spatownofSopot,andsuburbancommuni-
ties, which together form a metropolitan area called the
Tricity (Trójmiasto), with a population of over 800,000.
Gdansk itself has a population of 455,830 (June 2010),
making it the largest city in the Pomerania region of
Northern Poland.
The 608-bed regional hospital contains three internal
departments, cardiology, neurology, pediatric ward, sur-
gery,orthopedic,ICU(adult),ICUneonatal,obstetricsand
gynecology, neonatology, laryngology, ophthalmic ward
anddialysisunit.Theyearlyadmittancerateandaverage
hospitalizationtimearepresentedinTable1andTable2.
Population of the citizens with access to this hospital is
estimated on the level of 205,000.
Bacteriology lab has an access to the analytical software
WHONET (WHO) and VITEK (BioMerieux, France).
ThemodifiedepidemiologicalprocedureconcerningMRSA
carriersandpatients(Procedure1)hasbeenimplement-
ed within the hospital.
Procedure 1 is characterized by the following criteria:
• Epidemiological procedure concerning initial MRSA,
VISA or VRSA isolation.
• Patient suspected of being infected (colonized) with
MRSA, should be placed in a separate room, may be
provided with other patients who have had the pres-
ence of a strain.
• The patients prescribed to eradication treatment
should not be cohorted.
• The epidemiological investigation is being performed
to determine the origin of the strain.
• In the case of hospital-acquired infections, the high-
risk patients are being screened with microbiological
tests (nasal-throat, respiratory tract and rectal isol-
ations).
• Theemployedmedicalstaffistrainedovertheprophy-
laxis of MRSA, VISA and VRSA infections.
• The verification of the established epidemiological
procedures is performed.
Hospital no. 2
Koszalin is the largest city of Middle Pomerania in north-
western Poland, possess a county-status city and is a
capital of Koszalin County of West Pomeranian Voivode-
ship since 1999. Previously, it was a capital of Koszalin
Voivodeship(1950–1998).Populationofthecitizenswith
access to this hospital is estimated on the level of
650,000andKoszalinitselfhasapopulationof107,217
(2009).
The 609-bed regional hospital contains two internal
wards, cardiology, neurology, oncology, infectious dis-
eases ward, pediatric, children surgery, general surgery,
orthopedic, ICU (adult), ICU neonatal, obstetrics and
gynecology, neonatology, laryngology, ophthalmic ward,
dermatologyanddialysisunit.Thehospitalcharacteristics
have been presented in Table 3 and Table 4.
Bacteriology lab has an access to the analytical software
Marcel.
ThemodifiedepidemiologicalprocedureconcerningMRSA
carriers and patients (Procedure 2) has been employed
implemented in the hospital.
Procedure 2 is characterized by the following criteria:
• ProcedureoftreatmentofpatientssuspectedofMRSA
infection, infected (colonized) with MRSA (Methicillin
ResistantStaphylococcusaureus),VRSA(Vancomycin
Resistant Staphylococcus aureus), VRE (Vancomycin
ResistantEnterococci)referstomedicalstaff,support-
ing staff, staff of hospital hygiene
• Patient suspected of being infected (colonized) with
MRSA should be placed in a separate room, may be
provided with other patients who have had the pres-
ence of a strain
• Room equipped with items and equipment as the
standard isolation of infections spreading through
direct contact
indicated the use of single sheets •
in the case of reusable application, one should
proceed as in terms of dirty sheets
•
• Room doors must be closed
• Medical and hospital hygiene staff are informed on
the reason of isolation
• One entering the room should put on
disposable protective – apron, shoe pads, cap on
head
•
disposable non-sterile gloves for nursing activities,
sterile for aseptic operations
•
surgical mask in case of carrying of MRSA/VRSA/
VRE in patient's airway
•
beforeleavingtheroomtakeoffpersonalprotective
equipment and place in red bag
•
before performing the steps, in the course if neces-
sary,anduponcompletion,theprocedureforhygien-
ic hand-washing applies
•
• Mandatory reporting by consultants (visiting family) to
a designated nurse to obtain information about safety
precautions
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Table 2: Rate of MRSA isolation (hospital Gdansk)
Table 3: The characteristics of the hospital in Koszalin
Table 4: Rate of MRSA isolation (hospital Koszalin)
avoidance of unnecessary traffic in the hall of the
isolation ward
•
restriction of movements of the patient in the ward
andoutside–fullinformationabouttheprecaution-
ary measures
•
• Wasted disposable equipment, dressings, etc. are
subject to proceedings according to the instruction of
medical waste
• Reusable equipment is subject to disinfection pro-
cesses, cleaning and sterilization
• Dealing with surfaces contaminated with biological
material in accordance with the procedure for the
safety and handling of infectious material
• Hygienic treatment of patient:
the entire body must be washed daily with an anti-
septic for this purpose, hair shampoo 2x a week
•
the patient's bedding and linen change every day,
following the steps “on-bed” bedside management
of patient
•
• Cleaning the room twice a day and depending on the
needs
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MRSA/VRSA material for microbiological examination
should be collected from the nasal vestibule or peri-
neum, or groin, or areas of the affected skin; material
foradirectedsearchtowardsVREidentificationshould
be sampled from the anal area (or a stool sample) or
the perineum, lesions of the damaged skin or the
cathetered patient's urine sample
• Patients, who have had contact with microbiologically
diagnosedMRSA/VRSA/VREinfectedpatientorMRSA/
VRSA/VRE carrier, should be cohorted
• If a patient is diagnosed as MRSA/VRSA/VRE carrier
and if allowed by the clinical condition, the patient
should be discharged with recommendations for fur-
ther treatment aimed at eliminating the carrier state-
controlswabsshouldbetakenforatleast5daysafter
the procedure eliminating carrier state; it is advisable
to obtain a 3-time negative results
• The re-taking of the patient to the hospital or taking a
patient previously hospitalized in other wards/hos-
pitals,whereendemicorepidemicpresenceofMRSA/
VRSA/VRE was recorded, it is advisable to carry out
directed microbial diagnostics; until the results are
obtained, strict adherence to the principles of insula-
tion of directly transmitted infections must be applied
• Staff colonized with MRSA/VRSA/VRE should be re-
moved from contact with patients, until elimination of
thecarrierstate;beforetakingthejobamicrobiological
control of the MRSA/VRSA/VRE carrier state should
be performed, especially in the personnel previously
employed in hospitals where the MRSA/VRSA/VRE
were registered.
Results
According to comparative analysis performed for two re-
gional hospitals of Northern Poland with similar bed
numbers (608 vs. 609) and similar ward profiles, the
percentage of MRSA distribution was different. In 2008
athospitalno.1therateofMRSAtoallS.aureusisolates
was14.4%andathospitalno.2thesameratewas6.0%.
In 2009 these rates were 8.3% and 4.7%, respectively.
However, in 2010, the rate was similar for the two de-
scribed hospitals (Table 2 and Table 4). The differences
concernalsothenumberofhospitalizedpatients,hospit-
alization time and number of microbiological tests per-
formed (Table 1 and Table 3). At hospital no. 1 the num-
ber of hospitalized patients was approx. 25,000, the
hospitalization time was 6.6–6.7 days with percentage
of patients’ beds occupation of approx. 75%. At hospital
no. 2 the number of hospitalized patients was higher –
ca.31,000,neverthelesstheaveragehospitalizationtime
was shorter and was calculated as 4.6–4.9 days with
lower percentage of patients’ beds occupation
(62.3–68.2%). The high difference concerns also the
number of microbiological specimens. At hospital no. 1,
the number of specimens/100 patients was as follows:
in 2008 – 101.9, in 2009 – 110.7 and in 2010 – 122.7.
Athospitalno.2muchsmallernumberofspecimens/100
patients was performed in each year: 29.51, 32.1 and
45.6, respectively.
Discussion
In the last decade in Poland, the monitoring of MRSA in-
fections and carriers has been improved [11], [16]. Pre-
viously some health-associated centers introduced the
survey,andepidemiologicalproceduresconcerningMRSA
carriers and patients [11], [13], [18]. Currently, many
hospitals in Poland are involved within the European
project EARS-Net (http://ecdc.europa.eu/en/activities/
surveillance/EARS-Net/), what enables in future the uni-
fication of procedures and surveillance methods.
Nowadays,eachmedicalcenterformsitsownprocedures
on the basis of obtained results from epidemiological in-
vestigations. Both of described hospitals have already
been involved within the above-mentioned project. It is
clearly visible that the comparison of even very similar
hospitalsisquitedifficult.TwicemoreisolationsofMRSA
in 2008 at hospital no. 1 could result from regional epi-
demic settings. In that time one outbreak in internal was
noticed (4 infected patients, 1 carrier). Relatively, in
hospitalno.2inthesameyearinspiteofalowernumber
ofspecimenssendforbacteriologicalanalysis,therewere
more isolations of S. aureus (533 vs. 478) and smaller
number of isolation of MRSA with one outbreak in neuro-
logyward(4infectedpatientsand9carriers).Thoughthe
percentage of MRSA in 2010 year was slightly higher
(6.5%),wehaveobservedthedecreaseofMRSAhospital-
acquired infections from 3 and 4 in 2008–2009 to 0 in
2010. It is interesting that in both hospitals the number
of specimens send to bacteriology lab consequently in-
creased whereas the frequency of MRSA isolations de-
creased. In our opinion, it results from effective and
properly used procedures of MRSA surveillance. This
opinion could be supported by results from EARS-Net re-
port where overall in Poland MRSA isolation frequency in
2009 is 20% (http://ecdc.europa.eu/en/activities/
surveillance/EARS-Net/).
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